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Abstract
Background: The use of information technology in healthcare is fast becoming an alternative and supporting
method of providing many forms of services in a healthcare and health management setting. Telephone
technology is used readily to deliver services such as disease management, consultations and behaviour
coaching. Telemedicine provides a promising alternative and supporting service for face-to-face general
practice care. The aim of this review is to utilise a systematic review to collate evidence on the use of
telemedicine as a lead in and an alternative to general practice visits.
Methods/design: A systematic search of MEDLINE, CINAHL, the Cochrane Library and the International Clinical
Trials Registry Platform will be performed using the search terms for the intervention (telemedicine) and the
comparator (general practice) to search the databases. The systematic review aims to identify randomised control trials;
however, if none are identified, an updated search will be conducted to identify lower levels of evidence. Papers will
be reviewed and assessed for quality and data extracted using two reviewers; if consensus is required, a third
reviewer will be consulted. If applicable, a meta-analysis of relevant outcomes will be conducted. The protocol
has been reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses
protocols (PRISMA-P) guidelines.
Discussion: The intervention and comparator have the potential to provide a vast range of healthcare services to a
range of diseases and health conditions. There is likely to be difficulty in identifying relevant clinical outcome measures
for the patient population. A range of outcome measures will therefore be collected in the data extraction phase.
Systematic review registration: PROSPERO CRD42015025225
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Background
Telemedicine provides a promising alternative to face-
to-face general practice (GP) care [1]. This is particularly
true for sparsely populated regions where accesses to pri-
mary care is difficult and would require travelling long
distances [2, 3]. However, whilst the published evidence
has demonstrated that telemedicine is likely to be effect-
ive, there are inconsistencies in the available evidence [1].
In Australia, telemedicine is currently available for
specialist services and disease management including
videoconferencing by a specialist, consultant physician,
telepsychiatrist, consultant occupational physician, pain
medicine physician, palliative medicine physician or
neurosurgeon. Telemedicine is also currently available
worldwide for services such as teleradiology, behaviour
management support (smoking cessation) or remote mon-
itoring for cardiovascular disease [1]. Telephone contacts
have been considered similar when used for health pro-
motion, triage and providing long-term management [4].
Telephone consultations are currently being used in a
number of countries (including the UK, the USA and
Switzerland) as an alternative to a face-to-face GP con-
sultation, and it has been suggested to provide timely
care that is easily accessible [5]. Whilst there is some
evidence available for telemedicine for management
and monitoring in specific diseases, there is a dearth of
evidence for telephone consultation as an alternative
for general practice visits. A systematic review in 2010* Correspondence: m.downes@epinet.net
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failed to identify any publications for telemedicine as a
replacement to general practice visits [1].
The aim of this study is to undertake a systematic re-
view of the evidence on the use of telemedicine as a lead
in and an alternative to general practice visits. The partici-
pants, interventions, comparators and outcomes (PICO)
for this systematic review will be as follows:
 Participants: people looking to access general
practice services
 Intervention: telemedicine
 Comparator: normal care (face-to-face consultation)
 Outcomes: quality-adjusted life years, hospitalisation,
emergency department use, mortality, time to
treatment and other relevant service outcomes
Methods/design
A preliminary scoping search was conducted to identify ter-
minology for the search terms and the type of studies that
are likely to be available. This protocol has been reported
according to the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses protocols (PRISMA-P)
guidelines [6] (Additional file 1) and is registered with
PROSPERO (CRD42015025225).
Included study design
Systematic reviews and randomised control trials are con-
sidered the top level of evidence for decision-making, and
for this reason, these will be included. However, prelimin-
ary searches have not identified systematic reviews in our
population group of interest. If the systematic searches do
not identify relevant studies, the review will be expanded
to include cohort studies, case control studies and cross-
sectional studies.
Searches
The following sources will be searched for primary
studies:
 MEDLINE, MEDLINE in process via Ovid
 CINAHL via EBSCO
 The Cochrane Library
 International Clinical Trials Registry Platform
 Checking of citation lists of included studies and
relevant reviews
A combination of text words and Medical Subject
Headings (MeSH) terms (for MEDLINE and the Cochrane
Library) relating to telemedicine and general practice,
identified in the preliminary searches, will be used. There
will be no restriction on date, but publications will be
restricted to those published in the English language. Sam-
ple search strategies are provided (Additional file 2), and
these search terms will be adapted for each database.
The search results will be downloaded and imported
into EndNote X7.3.1 (Thomson Reuters, NY). Endnote
will be used to identify articles for inclusion using the
predetermined eligibility criteria. Duplicate records
will be identified and removed using the Endnote du-
plicate tool. Then, study selection will be carried out
manually in three stages based on the inclusion/exclu-
sion criteria:
1. Title screening will be carried out by one researcher
and checked by another researcher for consistency.
2. Abstract reading will be carried out by two
researchers and checked for consistency.
3. Full-text reading will be carried out by two
researchers and checked for consistency.
Where difference between researchers occurs, agree-
ment will be carried out either by consensus or by in-
cluding a third researcher. A Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA)




 The studies examined telephone consultations as an
alternative to direct access to general practice.
○The telephone consultation was patient initiated.
○The telephone consultation was carried out by a
general practitioner.
 The studies followed up participants for health-related
outcomes and/or healthcare utilisation.
 The studies analysed primary data.
 The studies were systematic reviews or randomised
control trials (or in the case that none of these
exists: The studies were cohort studies, case
control studies and/or cross-sectional studies).
Exclusion criteria:
 The studies only examined telemedicine in specific
disease populations.
 The studies examined only telemonitoring or
the use of telemedicine for the management
of disease.
 The studies examined only telemedicine used
as a follow-up that was initiated by the health
practitioner.
 The studies did not examine general practitioner-led
telemedicine (i.e. was a study on nurse-led or
specialist-led telemedicine).
 The studies outcomes were only patient satisfaction.
 The publications were narrative reviews.
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Data extraction
A standardised data extraction form will be used in the
data extraction process. Data extraction will be con-
ducted by one researcher and checked by a second re-
searcher. Where difference occurs, these will be resolved
through consensus or through a third reviewer. The data
extracted from the studies will include information on
the study characteristics, population baseline character-
istics, the intervention, the comparator and outcomes:
 Study characteristics: author year (or other study
identification), patient inclusion and exclusion
criteria, study design, country, randomisation
process, sample size, length of follow-up, statistical
methods employed and funding source.
 Population baseline characteristics: age, gender,
condition/illness, length of time since condition
occurred, comorbidities, setting, i.e. general
population vs. aged-care facilities and/or rural/remote
vs. urban and others.
 Intervention/comparator: baseline characteristic,
geographical setting, length of GP/telemedicine
consult and others.
 Outcomes: There will be no restriction by outcome
measures extracted, but outcomes of particular
interest include hospitalisation, emergency
department use, mortality, quality-adjusted life years
and service outcomes, such as time waiting to be
seen, time to treatment, time to secondary services,
follow-up completed, compliance to GP advice and
other outcome measures.
Quality assessment (risk of bias assessment)
Critical appraisal of studies that fulfilled both the inclu-
sion and exclusion criteria will be carried out independ-
ently by two researchers. Risk of bias for the included
RCTs will be assessed using the Cochrane Collabora-
tion’s ‘Risk of bias’ tool (Version 5.1.0.) [7]. Where any
disagreements occur between the first researcher and
the second, these will be marked and resolved through
consensus or through a third reviewer. Where studies of
other design are included, appropriate risk of bias
tools will be identified and utilised for the particular
type of study. The quality assessment of a study will
be used to determine the strength of evidence for the
outcome it represents and will be considered if a
meta-analysis is conducted.
Analysis
Meta-analysis will be conducted where appropriate if
two or more similar studies provide the same outcome
measures. Assessment of study heterogeneity and biases
will be considered when determining if a meta-analysis
is appropriate. Given the heterogeneity that is likely
between the methods of delivering a telemedicine inter-
vention, a random effects model will be used; however, if
the studies are sufficiently similar, a fixed effects model
may be considered. Statistical heterogeneity will be
assessed using the I2 statistic [8]. Systematic differences
due to publication bias will be investigated between re-
ported and unreported findings using funnel plots and
the Egger test [9].
Where meta-analysis is not possible, a narrative presen-
tation of the study results will be provided. The systematic
review and meta-analysis will be reported consistent with
the PRISMA guidelines [10]. The strength of the evidence
will be assessed using the Grading of Recommendations
Assessment, Development and Evaluation (GRADE)
guidelines to aid in the interpretation of the existing
evidence and presenting recommendations for practice
and future research [11].
Discussion
Recruitment for participants into a randomised control
trial for a population group that is seeking general prac-
tice care is difficult, and it is probable that the recruit-
ment methods for the included studies in this review
will vary greatly. Therefore, the results from the included
studies will need to be interpreted in the context of par-
ticipant recruitment, study quality and sample size. This
will also have an impact on the overall results and inter-
pretation of the systematic review. Aggregation of data
may not be possible, and a narrative review may be re-
quired. The authors will need to be careful when pre-
senting the data in a qualitative manner and incorporate
the included study limitations and biases in our inter-
pretation. However, findings from this review will be of
significant importance, given the increasing use of tele-
medicine and access to technology in health care. Dis-
parities in the existing evidence will be identified
especially in terms of health outcomes, and this will be
useful in informing future studies in this area.
Additional files
Additional file 1: Preferred Reporting Items for Systematic Review
and Meta-Analysis Protocols checklist. This additional file is a
completed PRISMA-P checklist for the current systematic review protocol.
(DOC 84.5 KB)
Additional file 2: Search criteria used for a systematic review in
telemedicine. The additional file includes the search terms that will be
used in each database to conduct a systematic review in telemedicine.
(PDF 86.5 KB)
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